Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study)

被引：0

作者：

Pascual-Izquierdo, Cristina ^{[1
]}

Llacer-Ferrandis, Ma. Jose ^{[1
]}

de-la-Iglesia, Almudena ^{[2
]}

Monsalvo-Saornil, Silvia ^{[2
]}

Menor-Gomez, Maria ^{[3
]}

Gil-Fernandez, Juan Jose ^{[3
]}

Chica-Gullon, Esther ^{[4
]}

alvarez-Roman, Maria Teresa ^{[5
]}

Perez-Segura, Gloria ^{[6
]}

Zafra, Denis ^{[6
]}

Ortuzar-Pasalodos, Ariana ^{[7
]}

Gonzalez-Gascon-y-Marin, Isabel Teresa ^{[8
]}

Moreno, Gemma ^{[9
]}

Arquero-Portero, Teresa ^{[10
]}

Moreno-Carbonell, Marta ^{[1
]}

Revilla, Nuria ^{[10
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Gregorio Maranon, Hematol, Madrid, Spain

[2] Hosp Univ Puerta Hierro, Hematol, Madrid, Spain

[3] Hosp Univ Principe Asturias, Hematol, Madrid, Spain

[4] Hosp Univ Getafe, Madrid, Spain

[5] Hosp Univ La Paz, Hematol, Madrid, Spain

[6] Hosp Univ 12 Octubre, Hematol, Madrid, Spain

[7] Hosp Univ Rey Juan Carlos, Hematol, Madrid, Spain

[8] Hosp Univ Infanta Leonor, Hematol, Madrid, Spain

[9] Hosp Univ Ramon & Cajal, Hematol, Madrid, Spain

[10] Hosp Univ Fdn Jimenez Diaz, Inst Invest Fdn Jimenez Diaz IIS FJD, Hematol, Madrid, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 02期

关键词：

avatrombopag; immune thrombocytopenia; ITP; TPO-RA;

D O I：

10.1111/bjh.19975

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immune thrombocytopenia (ITP) is a rare acquired disorder where thrombopoietin-receptor agonists have become mainstays of ITP treatment. With the recent approval of avatrombopag (AVA), real-world studies are essential to evaluate its efficacy and safety. Our study of 66 adult ITP patients treated with AVA showed a high response rate. After starting AVA, 74.2% did not require rescue medications, with minimal adverse effects. Additionally, 56.0% of patients reduced other ITP medications, and all patients aged >= 65 years responded to AVA. Results should be confirmed in larger studies, but AVA appears to be an effective and safe treatment for ITP patients.

引用

页码：652 / 656

页数：5

共 50 条

[1] Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
Al-Samkari, Hanny
Jiang, Debbie
Gernsheimer, Terry
Liebman, Howard
Lee, Susie
Wojdyla, Matthew
Vredenburg, Michael
Cuker, Adam
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (03) : 359 - 366
[2] Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
Wang, Zhifa
Zhang, Aijun
Xu, Zhongjin
Wang, Nan
Zhang, Jialu
Meng, Jinxi
Dong, Shuyue
Ma, Jingyao
Hu, Yu
Ouyang, Juntao
Chen, Zhenping
An, Qi
Cheng, Xiaoling
Wu, Runhui
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1958 - 1965
[3] Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study
Oladapo, Abiola
Kolodny, Scott
Vredenburg, Michael
Swallow, Elyse
Goldschmidt, Debbie
Sarathy, Kirthana
Lopez, Priscilla
Maitland, Hillary
Yee, John
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
[4] Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational study
Wang, Nan
Wang, Zhifa
Liu, Jingjing
Hu, Yu
Dong, Shuyue
Chen, Hui
Meng, Jinxi
Ma, Jingyao
Chen, Zhenping
Cheng, Xiaoling
Wu, Runhui
BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (03) : 935 - 943
[5] Outcomes of switching to avatrombopag following treatment failure with eltrombopag in paediatric immune thrombocytopenia: A real-world study in China
Cheng, Xiaoling
Wang, Zhifa
Dong, Shuyue
Ma, Jingyao
Meng, Jinxi
Wang, Xiaoling
Wu, Runhui
BRITISH JOURNAL OF HAEMATOLOGY, 2023, : 636 - 644
[6] Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group
Kuehne, Thomas
Berchtold, Willi
Michaels, Lisa A.
Wu, Runhui
Donato, Hugo
Espina, Bibiana
Tamary, Hannah
Rodeghiero, Francesco
Chitlur, Meera
Rischewski, Johannes
Imbach, Paul
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (12): : 1831 - 1837
[7] A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Cekdemir, Demet
Guvenc, Serkan
Ozdemirkiran, Fusun
Eser, Ali
Topts, Tayfur
Ozkocaman, Vildan
Sahin, Handan Haydaroglu
Turak, Esra Ermis
Esen, Ramazan
Comert, Melda
Sadrilo, Sevil
Aslaner, Muzeyyen
Ulu, Bahar Uncu
Karakus, Abdullah
Bapur, Derya Selim
Alacacioglu, Inci
Aydin, Demet
Tekinalp, Atakan
Namdaroglu, Sinem
Ceran, Funda
Tarkun, Pinar
Kiper, Demet
Cetiner, Mustafa
Yenerel, Mustafa
Demir, Ahmet Muzaffer
Yilmaz, Guven
Terzi, Hatice
Atilla, Erden
Malkan, Umit Yavuz
Acar, Kadir
Ozturk, Erman
Tombak, Anil
Sunu, Cenk
Salim, Ozan
Aslan, Nevin Alayvaz
Sayan, Ozkan
Ozan, Ulku
Ayer, Mesut
Gokgoz, Zafer
Andic, Neslihan
Kizilkilic, Ebru
Noyan, Figen
Ozen, Mehmet
Tanrikulu, Funda Pepedil
Alanoglu, Guchan
Ozkan, Hasan Atilla
Aslan, Vahap
Cetin, Guven
Erikci, Alev Akyol
Deveci, Burak
TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (04) : 230 - 237
[8] Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension
Al-Samkari, Hanny
Nagalla, Srikanth
PLATELETS, 2022, 33 (02) : 257 - 264
[9] Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
Elbedewy, Tamer A.
Elsebaey, Mohamed A.
Elkholy, Reem A.
Tahoon, Dina M.
Elshweikh, Samah A.
JOURNAL OF BLOOD MEDICINE, 2020, 11 : 533 - 542
[10] Combination therapy of dexamethasone, rituximab, and cyclosporine for adults with primary immune thrombocytopenia: a prospective observational study
Liang, Ying
Tang, Cong
Liu, Chunyu
Zhang, Lu
Fang, Yongguang
Zhao, Aixiang
Chen, Nannan
EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (11) : 855 - 860

← 1 2 3 4 5 →